Author:
Eckelman William C.,Boyd Marie,Mairs Robert J.
Publisher
Springer International Publishing
Reference163 articles.
1. Hopf C, Bantscheff M, Drewes G. Pathway proteomics and chemical proteomics team up in drug discovery. Neurodegener Dis. 2007;4(2–3):270–80.
2. Eckelman WC, Lau CY, Neumann RD. Perspective, the one most responsive to change. Nucl Med Biol. 2014;41(4):297–8.
3. Divgi C. Whither goest thou, radiopharmaceutical therapy? J Nucl Med. 2014;55(1):5–6.
4. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65(1–2):271–84.
5. Adams GP. Antibody fragments produced by recombinant and proteolytic methods. In: Stigbrand T, Carlsson J, Adams GP, editors. Targeted radionuclide tumor therapy: biological aspects. Dordrecht: Springer; 2008.